Inflammation and Triglycerides Partially Mediate the Effect of Prepregnancy Body Mass Index on the Risk of Preeclampsia
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
The objective of this study was to quantify the mediating role of inflammation and triglycerides in the association between prepregnancy body mass index (weight (kg)/height (m)2) and preeclampsia. The authors conducted a nested case-control study of 55 preeclamptic women and 165 pregnant controls from the Pregnancy Exposures and Preeclampsia Prevention Study (Pittsburgh, Pennsylvania, 1997-2001). Serum samples collected at < or = 20 weeks' gestation were analyzed for levels of C-reactive protein and triglycerides. The adjusted odds ratio (AOR) from a multivariable conditional logistic regression model assessing the total effect of body mass index on preeclampsia risk was compared with the AOR from the same model after results were controlled for C-reactive protein, triglycerides, and confounding factors (direct-effects model). The percentage of the total effect that was mediated through inflammation and triglycerides was calculated as 100 - [ln(direct-effects AOR)/ln(total-effects AOR)]. In the total-effects model, 4- and 8-unit increases in body mass index were associated with 1.7-fold (95% confidence interval (CI): 1.3, 2.3) and 2.9-fold (95% CI: 1.6, 5.2) increases in preeclampsia risk, whereas in the direct-effects model, these AORs were 1.4 (95% CI: 1.0, 1.9) and 2.0 (95% CI: 1.0, 3.8), respectively. Inflammation was a more important mediator than triglycerides. These findings suggest that approximately one third of the total effect of body mass index on preeclampsia risk is mediated through inflammation and triglyceride levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., Criqui, M., Fadl, Y. Y., Fortmann, S. P., Hong, Y., Myers, G. L., et al. (2003) · Circulation · doi:10.1161/01.cir.0000052939.59093.45 · Cited by 6,401 · cited 2×
“# Defined as a C-reactive protein level greater than 1.0 mg/dl ( 26 ).”
BackgroundInfluentialCausal Diagrams for Epidemiologic Research
Greenland, S., Pearl, J., & Robins, J. M. (1999) · Epidemiology · doi:10.1097/00001648-199901000-00008 · Cited by 3,728
Elevated C-reactive protein levels in overweight and obese adults
Visser, M. (1999) · JAMA · doi:10.1001/jama.282.22.2131 · Cited by 2,494 · cited 1×
“Overweight is associated with alterations in lipid concentrations and an activation of inflammatory markers (8, 9), and both of these metabolic abnormalities are characteristic of preeclamptic pregnancies before the onset of clinically evident disease (10, 11).”
BackgroundCausal diagrams for empirical research
PEARL, J. (1995) · Biometrika · doi:10.1093/biomet/82.4.669 · Cited by 2,355 · cited 1×
“A directed acyclic graph (24, 25) (figure 1) was used to determine potential confounders entered into each model.”
MethodBlack, S., Kushner, I., & Samols, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.r400025200 · Cited by 1,844
Hypertriglyceridemia as a cardiovascular risk factor
Austin, M. A., Hokanson, J. E., & Edwards, K. L. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00031-9 · Cited by 1,066 · cited 1×
“Nonfasting serum samples obtained at 20 weeks’ gestation were stored in aliquots at 80 C until they were assayed for C-reactive protein (CRP), a sensitive index of systemic inflammation (20), and triglycerides, an indicator of lipid status which, if elevated, is a marker of hyperlipidemia (21).”
MethodTrial of Calcium to Prevent Preeclampsia
Levine, R. J., Hauth, J. C., Curet, L. B., Sibai, B. M., Catalano, P. M., Morris, C. D., DerSimonian, R., Esterlitz, J. R., Raymond, E. G., Bild, D. E., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707103370201 · Cited by 634
Fallibility in estimating direct effects
Cole, S. R., & Hernán, M. A. (2002) · International Journal of Epidemiology · doi:10.1093/ije/31.1.163 · Cited by 548 · cited 1×
“To do this, we included CRP and confounders of the CRPpreeclampsia relation in the conditional logistic total-effects model (23) to fit ‘‘direct-effects model 1’’ (Appendix).”
MethodA Multivariate Analysis of Risk Factors for Preeclampsia
Eskenazi, B. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03470020063033 · Cited by 436
Hubel, C. (1998) · Seminars in Reproductive Medicine · doi:10.1055/s-2007-1016255 · Cited by 106
Cited by
Onuegbu, A. J., Olisekodiaka, J. M., Udo, J. U., Umeononihu, O., Amah, U. K., Okwara, J. E., & Atuegbu, C. (2015) · Medical Principles and Practice · doi:10.1159/000381778 · Cited by 2,044
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
Epidemiology of preeclampsia: impact of obesity
Jeyabalan, A. (2013) · Nutrition Reviews · doi:10.1111/nure.12055 · Cited by 433
Prepregnancy Body Mass Index and the Occurrence of Severe Hypertensive Disorders of Pregnancy
Bodnar, L. M., Catov, J. M., Klebanoff, M. A., Ness, R. B., & Roberts, J. M. (2007) · Epidemiology · doi:10.1097/01.ede.0000254119.99660.e7 · Cited by 266
Self-citationLow socioeconomic status is a risk factor for preeclampsia: the Generation R Study
Silva, L. M., Coolman, M., Steegers, E. A., Jaddoe, V. W., Moll, H. A., Hofman, A., Mackenbach, J. P., & Raat, H. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282fcc36e · Cited by 250
Metadata
- Authors
- Bodnar, L. M., Ness, R. B., Harger, G. F., & Roberts, J. M.
- Venue
- American Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-11-03
- Volume
- 162
- Issue
- 12
- Pages
- 1198-1206
- ISSN
- 0002-9262 (ISSN-L)
- 1476-6256
- OpenAlex
- W2127498163
- Cited by
- 147
- References
- 10
- FWCI
- 5.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.